{
    "organizations": [],
    "uuid": "29ff5a4f7885e56c42f318d26b94434215da6376",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-fda-provides-full-approval-to-prax/brief-fda-provides-full-approval-to-praxbind-specific-reversal-agent-for-pradaxa-idUSASC09W3T",
    "ord_in_thread": 0,
    "title": "BRIEF-FDA Provides Full Approval To Praxbind, Specific Reversal Agent For Pradaxa",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "April 17 (Reuters) - FDA-\n* FDA PROVIDES FULL APPROVAL TO PRAXBIND, SPECIFIC REVERSAL AGENT FOR PRADAXA\n* BOEHRINGER INGELHEIM SAYS U.S. FDA PROVIDED FULL APPROVAL FOR PRAXBIND , THE SPECIFIC REVERSAL AGENT FOR PRADAXA Source text for Eikon:\n ",
    "published": "2018-04-17T20:08:00.000+03:00",
    "crawled": "2018-04-18T18:13:57.000+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "april",
        "reuters",
        "fda",
        "provides",
        "full",
        "approval",
        "praxbind",
        "specific",
        "reversal",
        "agent",
        "pradaxa",
        "boehringer",
        "ingelheim",
        "say",
        "fda",
        "provided",
        "full",
        "approval",
        "praxbind",
        "specific",
        "reversal",
        "agent",
        "pradaxa",
        "source",
        "text",
        "eikon"
    ]
}